HALF YEARLY REPORT DECEMBER |
2022 |
Company Information | |||
Board of Directors | Mr. Yasir Ahmed Awan | Chairman | |
Mr. Imran Ghafoor | Chief Executive Officer | ||
Mrs. Sharmeen Imran | Non-Executive Director | ||
Mr. Haroon Ahmed Zuberi | Non-Executive Director | ||
Mr. Junaid Makda | Non-Executive Director | ||
Mr. Saqib Anjum | Non-Executive Director | ||
Mr. Saim Bin Saeed | Independent Director | ||
Chief Financial Officer | Mr. Shahid Irshad | ||
Company Secretary | Mr. Mazhar Ali Khan | ||
Head of Internal Audit | Mr. Zia-ul-Mustafa | ||
Audit Committee | Mr. Saim Bin Saeed | Chairman | |
Mr. Yasir Ahmed Awan | Member | ||
Mr. Haroon Ahmed Zuberi | Member | ||
Human Resource and | Mrs. Sharmeen Imran | Chairperson | |
Remuneration Committee | Mr. Imran Ghafoor | Member | |
Mr. Saqib Anjum | Member | ||
External Auditors | M/s Yousuf Adil | ||
Chartered Accountants | |||
Legal Advisor Registered | Sahibzada Waqar Arif | ||
Office | 601-602, Business Centre, Mumtaz Hassan | ||
Road, Off. I. I. Chundrigar Road, Karachi - 74000 | |||
Ph : (92 21) 32401373, 32413944 | |||
Company Website | www.sitaraperoxide.com | ||
Bankers | Al Baraka Bank (Pakistan) Limited | ||
Askari Bank Limited | |||
Bank Alfalah Limited | |||
Faysal Bank Limited | |||
Habib Bank Limited | |||
MCB Bank Limited | |||
Meezan Bank Limited | |||
National Bank Limited | |||
Soneri Bank Limited | |||
Standard Chartered Bank (Pakistan) Limited | |||
Summit Bank Limited | |||
United Bank Limited | |||
JS Bank Limited | |||
First Women Bank Limited | |||
Bank Al Habib Limited | |||
Share Registrar | THK Associates (Private) Limited | ||
Plot No. 32-C, Jami Commercial Street 2, | |||
DHA, Phase VII, Karachi - 75500, Pakistan. | |||
UAN: (92 21) 111-000-322 | |||
Ph: | (92 21) 35310183-84 | ||
Fax: | (92 21) 35310191 | ||
Head Office & Project | 26 - KM Sheikhupura Road, Faisalabad. Ph : | ||
Location | (92 41) 2400900-2,2400904-5 | ||
Sitara Peroxide Limited // Half Yearly Dec 31, 2022 | 1 |
Directors' Report
DIRECTORS REVIEW
I, on the behalf of Board of Directors of your Company, have pleasure in presenting you the un-audited condensed interim financial information for the half year ended December 31, 2022.
The quarter under review has been very testing period for your Company. The Company is facing challenge of unprecedented rise in tariff of RLNG . The Company uses RLNG as feedstock in manufacturing of Hydrogen Peroxide and its captive power house in also run on RLNG . Unlike exporters, fertilizer manufac turers etc which receive natural gas at subsidized rate, local Hydrogen Peroxide manufacturing industry is exposed to fluctuations in tariff of RLNG in international market. Global demand of RLNG has been on higher side and global supply has been facing bottlenecks; resulting in higher tariff of RLNG to hydrogen peroxide manufacturing industry.
Net sales during the six months period under review remained Rs. 386 million against net sales of Rs. 1,044 million during the corresponding period of financial last year. Drop in turnover during the period is due to decrease in sales volume; and sales volume decreased due to lower capacity utilization of plant. Cost of sales remained to Rs. 499 million as compared to 986 million. Due to lower capacity utilization and rising cost of production, gross margins of your C ompany remained negative. During first six months, Company incurred net loss after tax of Rs. 220 million and loss per share of Rs. 3.99; as against net loss after tax of Rs. 92 million and loss per share of Rs. 1.67 in corresponding period of last financial year.
During quarter ended December 31, 2022, net sales remained Rs. 71 million against net sales of Rs. 594 million during the corresponding period of financial last year. Cost of sales remained Rs. 145 million as compared to 511 million. The Company incurred net loss after tax of Rs. 111 million and loss per share of Rs. 2.01 against profit after tax of Rs. 7 million and earning per share of Rs. 0.13 in comparative quarter of corresponding financial year.
Despite all challenges, management of the Company has been positive about future business outlook. Demand of hydrogen peroxide and its prices are expected to remain strong in future. We are confident of much improved financial performance in second half of ongoing financial year.
The Board takes this opportunity to thank all stakeholders for their continued support. We also appreciate and acknowledge the continued commitment and hard work of our employees.
Allah may give us the courage to face the challenges ahead. Aameen
On behalf of Board of Directors
Faisalabad | HAROON AHMED ZUBERI | IMRAN GHAFOOR |
April 04, 2023 | Director | Chief Executive Officer |
2 | Sitara Peroxide Limited // Half Yearly Dec 31, 2022 |
Directors' Report | |
Sitara Peroxide Limited // Half Yearly Dec 31, 2022 | 3 |
Auditors' Review Report
INDEPENDENT AUDITORS' REVIEW REPORT
TO THE MEMBERS OF SITARA PEROXIDE LIMITED
REVIEW OF INTERIM FINANCIAL STATEMENTS
Introduction
We have reviewed the accompanying condensed interim statement of financial position of Sitara Peroxide Limited (the Company) as at December 31, 2022, the related condensed interim statement of profit or loss, condensed interim statement of comprehensive income, condensed interim statement of changes in equity, and condensed interim statement of cash flows and notes to the financial statements for the six month period then ended (here-in-after referred to as the "interim financial statements"). Management is responsible for the preparation and presentation of these interim financial statements in accordance with accounting and reporting standards as applicable in Pakistan for interim financial reporting. Our responsibility is to express a conclusion on these interim financial statements based on our review.
The figures of the condensed interim statement of profit or loss, condensed interim statement of comprehensive income for the three-month period ended December 31, 2022 and related comparative information have not been reviewed, as we are required to review only the cumulative figures for the six month period ended December 31, 2022.
Scope of Review
We conducted our review in accordance with International Standard on Review Engagements 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity". A review of interim financial statements consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Conclusion
Based on our review, nothing has come to our attention that causes us to believe that the accompanying interim financial statements are not prepared, in all material respects, in accordance with the accounting and reporting standards as applicable in Pakistan for interim financial reporting.
Emphasis of Matter
During the period, the Company has incurred a gross loss and net loss for the period of Rs.
- million and Rs. 220.06 million respectively (June 30, 2022: Rs. 63.20 million and Rs.
- million respectively), and as at December 31, 2022, current liabilities exceed current assets by Rs. 349.09 million (June 30, 2022: Rs.107.67 million). The Company was unable to pay installments of long term financing and rental payments of sukuks of Rs. 177.46 million (June 30, 2022: Rs. 174.67 million). The plant of the Company has remained shut down from October 20, 2022 until March 02, 2023. These conditions along with other matters as disclosed in note 1.2 to interim financial statements, indicate the existence of material uncertainty about company's ability to continue as going concern.
These financial statements have been, however, prepared on going concern basis for the reasons more fully explained in note 1.2 to these interim financial statements.
The engagement partner on the review resulting in this independent auditor's review report is Muhammad Sufyan.
Chartered Accountants
Lahore
Date: April 18, 2023
UDIN: RR202210180n4fPx6TYw
4 | Sitara Peroxide Limited // Half Yearly Dec 31, 2022 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Sitara Peroxide Ltd. published this content on 26 April 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 April 2023 07:16:01 UTC.